+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Vaccines Global Market Report 2020

  • ID: 4871551
  • Report
  • December 2019
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Bavarian Nordic
  • CSL Limited
  • Glaxosmithkline
  • NOVARTIS AG
  • Pfizer
  • MORE

Vaccines Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global vaccines market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Vaccines Market Global Report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market:

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

  • Markets Covered: 1) By Type: Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others) 2) By Technology: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines 3) By Route of Administration: Intramuscular (IM), Subcutaneous (SC), Oral, Others 4) By Valance: Monovalent, Multivalent 5) By Distribution Channel: Institutional Sale, Hospital Pharmacies, Retail Pharmacies
  • Companies Mentioned: AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck, Pfizer
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Bavarian Nordic
  • CSL Limited
  • Glaxosmithkline
  • NOVARTIS AG
  • Pfizer
  • MORE
1. Executive Summary

2. Vaccines Market Characteristics

3. Vaccines Market Size And Growth
3.1. Global Vaccines Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Vaccines Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Vaccines Market Segmentation
4.1. Global Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Anti-Infective Vaccines
  • Autoimmunity
  • Others (Cancer And Others)
4.2. Global Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Conjugate Vaccines
  • Inactivated and Subunit Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines
4.3. Global Vaccines Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Intramuscular (IM)
  • Subcutaneous (SC)
  • Oral
  • Others
4.4. Global Vaccines Market, Segmentation By Valance, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Monovalent
  • Multivalent
4.5. Global Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Institutional Sale
  • Hospital Pharmacies
  • Retail Pharmacies
5. Vaccines Market Regional And Country Analysis
5.1. Global Vaccines Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Vaccines Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Vaccines Market
6.1. Asia-Pacific Vaccines Market Overview
6.2. Asia-Pacific Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Vaccines Market
7.1. China Vaccines Market Overview
7.2. China Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Vaccines Market
8.1. India Vaccines Market Overview
8.2. India Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Vaccines Market
9.1. Japan Vaccines Market Overview
9.2. Japan Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Vaccines Market
10.1. Australia Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Vaccines Market
11.1. Indonesia Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Vaccines Market
12.1. South Korea Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Vaccines Market
13.1. Western Europe Vaccines Market Overview
13.2. Western Europe Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Vaccines Market
14.1. UK Vaccines Market Overview
14.2. UK Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Vaccines Market
15.1. Germany Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Vaccines Market
16.4. France Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Vaccines Market
17.1. Eastern Europe Vaccines Market Overview
17.2. Eastern Europe Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Vaccines Market
18.1. Russia Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Vaccines Market
19.1. North America Vaccines Market Overview
19.2. North America Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Vaccines Market
20.1. USA Vaccines Market Overview
20.2. USA Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Vaccines Market
21.1. South America Vaccines Market Overview
21.2. South America Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Vaccines Market
22.1. Brazil Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Vaccines Market
23.1. Middle East Vaccines Market Overview
23.2. Middle East Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Vaccines Market
24.1. Africa Vaccines Market Overview
24.2. Africa Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Vaccines Market Competitive Landscape And Company Profiles
25.1. Vaccines Market Competitive Landscape
25.2. Vaccines Market Company Profiles
25.2.1. AstraZeneca
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Emergent Biosolutions
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Glaxosmithkline
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Merck
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Pfizer
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Vaccines Market

27. Vaccines Market Trends And Strategies

28. Product Pipeline Analysis

29. Vaccines Market Future Outlook and Potential Analysis

30. Appendix
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Bavarian Nordic
  • CSL Limited
  • Glaxosmithkline
  • NOVARTIS AG
  • Pfizer
  • MORE

The vaccines market consists of sales of vaccines and related services. This industry includes establishments that produce anti-infective vaccines, autoimmunity vaccines and vaccines for cancer and other diseases. Vaccines create antibody-antigen reaction that helps in attaining resistance to the disease causing organism. Vaccines include recombinant vaccines, conjugate vaccines, live attenuated vaccines, inactivated vaccines, toxoid vaccines and others.

The global vaccines market was valued at about $29.64 billion in 2018 and is expected to grow to $43.79 billion at a CAGR of 10.3% through 2022.

Rising awareness on immunization and vaccination benefits in emerging markets is consistently driving the global vaccines market growth. World Health Organization (WHO) is taking initiatives to increase awareness of immunization through global vaccine action plan (GVAP) and global Immunization vision and strategy (GIVS). They aim to strengthen routine immunization, control morbidity and mortality from vaccine preventable diseases and help countries to immunize more people with a greater range of vaccines. The Organization accomplishes this work through its biological programme, the WHO Collaborating Centers, and the WHO Expert Committee on Biological Standardization (ECBS). In 2017, according to WHO statistics,85% of the total infants across the globe, (116.2 million) received 3 doses of diphtheria-tetanus-pertussis vaccine in order to increase immunization and protect them against infectious diseases that can cause serious illness and disability. Furthermore, 123 countries reached 90% coverage of DTP3 vaccine in 2017.

The vaccines market growth is limited due to severe shortage of skilled healthcare professionals for developing biologics drugs which requires specialized skillsets. These skillsets are limited to some research organizations and medical equipment companies in the USA and Europe, this is expected to be a major restraint on the market. As of 2018, 40% of the biopharma industry was facing difficulties in hiring for process development staff due to shortage of talent. This shortage also led to rise in competition and salaries for the limited talent pool available for biologics talent, thereby further limiting growth of the market.

The vaccines market has been witnessing multiple strategic initiatives and mergers and acquisitions in the recent years. Top companies in the market are strategically acquiring start-ups and mid-sized companies to broaden products and services. For instance, in February 2019, Bharat Biotech acquired Chiron Behring Vaccines, a clinical biotechnology company, one of the leading manufacturers of rabies vaccines across the globe. Similarly, in 2017, Takeda Pharmaceutical acquired ARIAD Pharmaceuticals for approximately $5.2 billion, and Sanofi acquired Protein Sciences for $650 million. Companies in the industry are increasingly realigning their portfolios and pursuing profitable inorganic growth opportunities. Additionally, M&A interest is also being fueled by stronger corporate balance sheets, liquid debt markets, and continued favorable interest rates globally.

The Food and Drug Administration (FDA) is the National Regulatory Authority (NRA) in the United States responsible for assuring quality, safety, and effectiveness of all vaccines for human use. Center for Biologics Evaluation and Research (CBER) within the US FDA is responsible for regulating vaccines market. Governments across the world are encouraging the research and development of biologics in order to develop more targeted therapies and vaccines for various diseases. In May 2014, the US’s FDA announced a fast-track initiative to review its drugs and biologics policy to speed the availability of therapies to patients with serious conditions, orphan drugs for rare disease, while preserving the safety and efficacy standards. In 2016, FDA also removed a rule (Section 610.21 of the FDA code) which specified minimal potency limits for certain antibodies and antigens. . In addition, FDA is also updating regulations (Section 610.53 of FDA code) regarding storage periods and storage conditions for biologics.

In October 2018, Emergent BioSolutions, a multinational specialty biopharmaceutical company, acquired PaxVax for $270 million. This acquisition would strengthen and expand Emergent BioSolution's product portfolio with PaxVax's typhoid vaccine Vivotif, cholera vaccine Vaxchora and additional clinical-stage vaccine used in the prevention of typhoid fever, cholera, chikungunya and other emerging infectious diseases. PaxVax is a company focused on developing, manufacturing, and commercializing specialty vaccines that protect against existing and emerging infectious diseases. PaxVax was founded in 2006 and is headquartered in Cayman Islands, a British Overseas Territory.

Major players in the market are AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck, Pfizer

Note: Product cover images may vary from those shown
5 of 5
  • AstraZeneca
  • Emergent Biosolutions
  • Glaxosmithkline
  • Merck
  • Pfizer
  • Sanofi Pasteur
  • Abbott
  • Astellas Pharma
  • Bavarian Nordic
  • CSL Limited
  • Daiichi Sankyo Company
  • Johnson & Johnson
  • Mitsubishi Tanabe Pharma Corporation
  • Serum Institute of India
  • Takeda Pharmaceutical Co. Ltd.
  • Biological E Limited
  • BiondVax Pharmaceuticals Ltd
  • Bristol-Myers Squibb
  • Inovio Pharmaceuticals Inc.
  • Madison Vaccines Incorporated
  • NOVARTIS AG
  • Novavax Inc.
  • Panacea Biotec
  • Sinovac Biotech Ltd.
  • Valneva SE
  • VBI Vaccine Inc
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll